Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Multiple Sclerosis

Free Subscription 25.05.2026 1 Ann Neurol 2 Arch Phys Med Rehabil 1 BMC Neurol 1 Can J Neurol Sci 1 J Neuroimmunol 4 J Neurol 1 J Neurol Neurosurg Psychiatry 3 J Neurol Sci 2 Mult Scler 1 Nat Rev Neurol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. DING Y, Hamitouche D, Thebault S, Kearns P, et al
   Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis.
   Ann Neurol. 2026 May 22. doi: 10.1002/ana.78256.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. MISTRETTA EG, Ehde DM, Turner AP, Alschuler KN, et al
   Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis.
   Arch Phys Med Rehabil. 2026 May 17:S0003-9993(26)00729.
   PubMed         Abstract available
   
   
3. DONKERS SJ, Lohse KR, Melam GR, Buragadda S, et al
   Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trial.
   Arch Phys Med Rehabil. 2026 May 17:S0003-9993(26)00706.
   PubMed         Abstract available
   
   

   
   BMC Neurol

4. AHMED GU, Abbas H, Komal F, Muskan F, et al
   Efficacy of transcranial direct current stimulation on motor and cognitive functions in patients with multiple sclerosis: a systematic review and meta-analysis.
   BMC Neurol. 2026 May 15. doi: 10.1186/s12883-026-04961.
   PubMed         Abstract available
   
   

   
   Can J Neurol Sci

5. OZDEMIR O, Batuk IT, Cetin H, Acar Ozen P, et al
   Acute Effects of Virtual Reality-Based Optokinetic Stimulation: Comparison of Individuals with Multiple Sclerosis With and Without Central Vestibular Dysfunction.
   Can J Neurol Sci. 2026 May 22:1-33. doi: 10.1017/cjn.2026.10622.
   PubMed        
   
   

   
   J Neuroimmunol

6. LI V, Pandey K, Binder MD, Reid HH, et al
   Identification of an immunogenic epitope from RASGRP2 with specificity for HLA-DR15 in multiple sclerosis.
   J Neuroimmunol. 2026;418:578971.
   PubMed         Abstract available
   
   

   
   J Neurol

7. SURCINELLI A, Panzera I, Piscaglia MG, Zagnoli S, et al
   Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study.
   J Neurol. 2026;273:332.
   PubMed         Abstract available
   
   
8. ROMANO F, Valsasina P, Albergoni M, Amato MP, et al
   Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.
   J Neurol. 2026;273:325.
   PubMed         Abstract available
   
   
9. GUO J, Johansson E, Hillert J, Olsson T, et al
   Trajectories of processing speed in multiple sclerosis across disease-modifying therapies.
   J Neurol. 2026;273:324.
   PubMed         Abstract available
   
   
10. BERGAMASCHI R, Ferraro OE, Pisoni E, Fronza M, et al
    Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study.
    J Neurol. 2026;273:319.
    PubMed        
    
    

    
    J Neurol Neurosurg Psychiatry

11. ROOS I, Sharmin S, Horakova D, Kubala Havrdova E, et al
    Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.
    J Neurol Neurosurg Psychiatry. 2026 May 20:jnnp-2026-338424.
    PubMed         Abstract available
    
    

    
    J Neurol Sci

12. SHIRANI A, Fiol J
    Seeing the unseen in multiple sclerosis: From reactive care to anticipatory medicine.
    J Neurol Sci. 2026;487:126009.
    PubMed        
    
    
13. NAGRODZKI J, Proitsi P, Tan M, Dobson R, et al
    No evidence for a causal link between plasma lipids and multiple sclerosis susceptibility and severity: A Mendelian randomisation study.
    J Neurol Sci. 2026;487:125986.
    PubMed         Abstract available
    
    
14. SINHA AP
    Comment on "A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis".
    J Neurol Sci. 2026;487:125962.
    PubMed        
    
    

    
    Mult Scler

15. NAZZI C, Turrini S, Pezzetta R, Scarpazza C, et al
    Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms through neuroplasticity.
    Mult Scler. 2026 May 19:13524585261442777. doi: 10.1177/13524585261442777.
    PubMed         Abstract available
    
    
16. POISSON KE, Anjum R, Gyang T, Eisner M, et al
    Impact of adverse childhood experiences on long-term quality of life in adults with pediatric-onset multiple sclerosis.
    Mult Scler. 2026 May 20:13524585261444237. doi: 10.1177/13524585261444237.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

17. PROSPERINI L, Tortorella C, Barkhof F, Battistini L, et al
    Rethinking prognosis in multiple sclerosis: a multiaxial perspective.
    Nat Rev Neurol. 2026 May 19. doi: 10.1038/s41582-026-01212.
    PubMed         Abstract available
    
    

    
    PLoS One

18. ALWABRAN AI, Aldoseri GM, Aldoseri GM, Mohager SO, et al
    Decoding the genetic basis of demyelination: Prediction of potential pathogenic coding and regulatory noncoding MBP SNPs in multiple sclerosis.
    PLoS One. 2026;21:e0347598.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum